与upadacitinib的联合治疗消除了瘤向IL-2融合蛋白的全身毒性
相关实验视频
Updated: May 15, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
927
Giulia Rotta1,2, Eleonora Prodi1,2, Frauke Seehusen3
1Philochem AG, Otelfingen, Switzerland.
Journal for immunotherapy of cancer
|May 11, 2025
概括
将向性互白素-2 (IL-2) 治疗与信号抑制剂相结合,可以提高癌症治疗的耐受性和疗效. 这种方法掩盖了毒性,允许更高,潜在的治疗剂量IL-2.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物制药工程 生物制药工程
背景情况:
- 在瘤学中,复合互白素-2 (IL-2) 治疗面临剂量限制性毒性,如血管泄漏综合征.
- 抗体-IL-2融合蛋白显示出希望,但可能导致早期副作用,限制治疗剂量升级.
- 需要具有"按需活动"的IL-2产品来掩盖非瘤活动而不牺牲疗效.
研究的目的:
- 设计具有"按需活动"的IL-2生物制药,以便在给药时降低毒性.
- 通过掩盖系统性影响来实现瘤特定的IL-2活性.
- 探索用信号抑制剂和药理动力学匹配的组合治疗.
主要方法:
- 利用瘤定位的F8-IL2融合蛋白向纤维素结合变体.
- 通过同时使用快速清除的信号抑制剂upadacitinib,掩盖了非瘤毒性.
- 通过组织病理学,和细胞因子水平监测血管泄漏综合征;进行免疫分析.
主要成果:
- 在小鼠的组合治疗显著改善了耐受性,而不会失去治疗活性.
- 保护小鼠免受减肥,全身细胞因子释放和严重的血管泄漏综合征的影响.
- F8-IL2控制了瘤的生长,并保持了免疫活性,增加了自然杀手和细胞毒性T细胞的透.
结论:
- 组合疗法允许使用向IL-2的潜在治疗剂量.
- 这一策略可以使健康的器官免受与IL-2疗法相关的危及生命的毒性.
- 建议一种有希望的方法来提高基于IL-2的癌症治疗的安全性和有效性.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.4K
相关概念视频
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K